Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
about
The palmitoyl acyltransferase HIP14 shares a high proportion of interactors with huntingtin: implications for a role in the pathogenesis of Huntington's diseaseThe physiology of protein S-acylationIdentification of a Novel Sequence Motif Recognized by the Ankyrin Repeat Domain of zDHHC17/13 S-AcyltransferasesDysregulated striatal neuronal processing and impaired motor behavior in mice lacking huntingtin interacting protein 14 (HIP14)Sudden death due to paralysis and synaptic and behavioral deficits when Hip14/Zdhhc17 is deleted in adult mice.Fatty acylation of proteins: The long and the short of it.Protein post-translational modifications: In silico prediction tools and molecular modeling.Altered Neuronal Dynamics in the Striatum on the Behavior of Huntingtin Interacting Protein 14 (HIP14) Knockout MiceLow levels of human HIP14 are sufficient to rescue neuropathological, behavioural, and enzymatic defects due to loss of murine HIP14 in Hip14-/- mice.A systematic analysis of protein palmitoylation in Caenorhabditis elegansDifferential loss of thalamostriatal and corticostriatal input to striatal projection neuron types prior to overt motor symptoms in the Q140 knock-in mouse model of Huntington's disease.Identification of palmitoyltransferase and thioesterase enzymes that control the subcellular localization of axon survival factor nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2)Identification of binding sites in Huntingtin for the Huntingtin Interacting Proteins HIP14 and HIP14LStriatal synaptic dysfunction and hippocampal plasticity deficits in the Hu97/18 mouse model of Huntington diseaseThe role for alterations in neuronal activity in the pathogenesis of polyglutamine repeat disorders.Endoplasmic reticulum localization of DHHC palmitoyltransferases mediated by lysine-based sorting signalsCombined serial analysis of gene expression and transcription factor binding site prediction identifies novel-candidate-target genes of Nr2e1 in neocortex development.Curation of the Mammalian Palmitoylome Indicates a Pivotal Role for Palmitoylation in Diseases and Disorders of the Nervous System and Cancers.Ca(2+) handling in isolated brain mitochondria and cultured neurons derived from the YAC128 mouse model of Huntington's diseaseA critical window of CAG repeat-length correlates with phenotype severity in the R6/2 mouse model of Huntington's disease.Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington's disease.Fat chance! Getting a grip on a slippery modification.Loss of corticostriatal and thalamostriatal synaptic terminals precedes striatal projection neuron pathology in heterozygous Q140 Huntington's disease mice.Memory and synaptic deficits in Hip14/DHHC17 knockout mice.Pathophysiology of Huntington's disease: time-dependent alterations in synaptic and receptor function.Convergent pathogenic pathways in Alzheimer's and Huntington's diseases: shared targets for drug development.G-protein signaling, lipid rafts and the possible sites of action for the antidepressant effects of n-3 polyunsaturated fatty acids.Targeting protein palmitoylation: selective inhibitors and implications in disease.Palmitoylation and depalmitoylation defects.SwissPalm: Protein Palmitoylation database.Roles of palmitoylation in axon growth, degeneration and regeneration.Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.Real-time imaging of glutamate clearance reveals normal striatal uptake in Huntington disease mouse models.The Protein Acyl Transferase ZDHHC21 Modulates α1 Adrenergic Receptor Function and Regulates Hemodynamics.Tracking brain palmitoylation change: predominance of glial change in a mouse model of Huntington's disease.Peptide array-based screening reveals a large number of proteins interacting with the ankyrin-repeat domain of the zDHHC17 S-acyltransferase.Palmitoylation and the trafficking of peripheral membrane proteins.Smarter neuronal signaling complexes from existing components: how regulatory modifications were acquired during animal evolution: evolution of palmitoylation-dependent regulation of AMPA-type ionotropic glutamate receptors.Hip14l-deficient mice develop neuropathological and behavioural features of Huntington disease.Palmitoylation of caspase-6 by HIP14 regulates its activation.
P2860
Q24293871-52F18887-934A-4C0B-AF41-C33EAD5AFB5BQ27014134-0F0B2531-AD67-4B64-856F-53F84CD14C22Q28119142-CE7838E0-5AA1-46B5-AD7E-F81A6E306D83Q28537948-5C0F6618-2D93-4970-9AD7-2D880ADF4BBAQ30367884-23A234FD-755F-436F-AF7C-4B5FF63E1D26Q30388573-4405BDF1-B991-42B4-930B-34B68E44703AQ33580119-979519C9-D52B-4735-A082-4D84023CEEC7Q33772223-73A58F8E-785F-4FE4-946C-4BB582345470Q34287351-BC9B036D-210F-4EEA-84B9-6C1952638CDFQ34318514-49E678BC-E141-4D44-BC69-1288B7C5D869Q34341619-B9EB35A8-37B5-481A-A494-6725C9ADF89DQ34552744-8D3CD737-A797-4926-B8B8-2D36F4D22CECQ35126285-569321F8-E21D-474E-B624-EA634898E92BQ35146890-7EAF562F-9D4C-4191-A0BD-6DD3CB3D9068Q35340099-6138FCCD-7258-4FBF-9D55-D4F5C810F213Q35604442-B7D34169-4444-4FE5-9826-2AE9EEFC17EBQ35708657-294ADC1E-3977-43B1-9520-852F1D0FC149Q35746623-2623B436-739D-4104-8B1D-791FA2D8D660Q35893954-8CB89306-37CA-4CE6-B823-E6D61E941659Q35951187-8D019B2F-8E3D-4804-B196-3725AADD7664Q36283269-ACF4F1DD-6AAF-4837-B404-E035DA7E5EC7Q36957153-0EC2A787-5146-4C2B-AECE-3742AC68F016Q37255018-9E25132C-4EB1-437B-84C7-B7D69AF7D269Q37395240-52281EF6-D17C-4F99-ADED-F7905A781270Q37930190-16B8871D-F555-4224-835A-AB3896042165Q37947984-040F2562-0C9C-4DA1-8349-AB5C64250C42Q38097891-74E41B5C-7204-4790-B471-B309B793BF5CQ38223437-FC20059B-E2A0-4395-A051-6A3D23299C9DQ38236849-04880E5B-C9EF-4947-B8BF-98953515ECB7Q38458236-EC0935E3-982E-430B-86E6-F1C3DDBDD6D1Q39114931-33DB7DA2-64DF-4EB4-B111-7FCC5940F8F4Q40102175-64E1B948-EB52-41B8-9B8E-1E6E92C57D21Q40104806-C550DE41-7494-4D23-9B41-3BFD4D16579BQ40159975-4ABE1296-588B-4915-9BD6-29A9787E0D68Q41849552-016125B7-72EE-40B0-8101-E9D7EF9BDBE2Q42636157-F014176C-B1B4-4F5C-9B01-31E9C940AD36Q44406066-3CC296A0-DCE2-4735-BD70-83C9CD1A73FBQ44998217-74B4E4D6-0CEA-413B-A0F5-7DE825143E4EQ45290323-FC839157-D1C3-42E2-95E1-0BEDC5172356Q45299287-E7898C02-CFE2-49D2-A27C-B55208FFF9A8
P2860
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
@ast
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
@en
type
label
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
@ast
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
@en
prefLabel
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
@ast
Altered palmitoylation and neuropathological deficits in mice lacking HIP14.
@en
P2093
P2860
P50
P356
P1476
Altered palmitoylation and neuropathological deficits in mice lacking HIP14
@en
P2093
Austen J Milnerwood
Crystal Doty
Jason P Lerch
Junmei Wan
Kuljeet Vaid
Nagat Bissada
Nicholas G Davis
R Mark Henkelman
Renaldo C Drisdel
P2860
P304
P356
10.1093/HMG/DDR308
P577
2011-07-20T00:00:00Z